Immuno12 &13 Tolerance & Autoimmunity

download Immuno12 &13 Tolerance & Autoimmunity

of 35

Transcript of Immuno12 &13 Tolerance & Autoimmunity

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    1/35

    Pharm-Immuno 12&13

    Immunologic Tolerance &

    AutoimmunityDr. Saber Hussein

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    2/35

    Objectives

    1.Define and explain the concept of immunologictolerance

    2.Categorize the conditions that influence tolerance

    induction3.Know the mechanisms that induce self-tolerance

    4.Know the benefits & disadvantages of tolerance

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    3/35

    Tolerance & Anergy

    Tolerance: The acquisition of a specific nonresponsiveness to a

    molecule recognized by the immune system as nonself

    Tolerogen:

    An otherwise immunogenic substance that, because of itschemical composition, dose, or route of introduction,induces immunologic tolerance rather than immunity

    Anergy:

    An absence of cell-mediated immune reaction in supposedly

    sensitized animals or individuals. No allergic response to an

    immunogen or allergen

    In advanced cases of TB, infections withMycobacterium

    tuberculosis, the tuberculin test becomes negative

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    4/35

    Central & peripheral

    tolerance to self Ags

    Central tolerance

    Immature lymphocytes

    specific for self Ags

    may encounter these

    Ags in the generative

    lymphoid organs (bone

    marrow & thymus) andare deleted

    Peripheral tolerance

    Mature self-reactive

    lymphocytes may be

    inactivated ordeleted

    by encounter with self

    antigens in peripheral

    lymphoid tissues

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    5/35

    Consequences of the lymphocyte-Ag encounter Naive lymphocytes may be activated to proliferate and differentiate

    by immunogenic antigens Tolerance is induced when tolerigenic antigens induce

    functional anergy (unresponsiveness) or

    apoptosis, leading to an inability of the cells to again respond to the sameAg even in an immunogenic form

    Some Ags are ignored

    by lymphocytes,

    resulting in no

    response, but the

    lymphocytes arecapable of responding

    to the same antigen in

    an immunogenic form

    Fig 9-1

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    6/35

    Tolerance

    induction

    Tolerance is a

    secondary

    "nothing"

    response

    Conditions that influence tolerance induction:

    1. The immunologic maturity of an animal & its immune cells

    2. The dose of Ag

    3. The physico-chemical nature of the Ag

    4. Immunogenicity of an Ag

    5. Route of Ag administration

    6. Kind of recipient

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    7/35

    Mechanisms that induce self-tolerance

    Three principal mechanisms that induce self-tolerance:

    [1] Physical elimination or clonal deletion

    [2] Functional inactivation, anergy

    [3] Regulated inhibition of Ag-reactive T & B cells Induction of self-tolerance can occur at three levels:

    i. The T-cell level

    ii. The B-cell leveliii. The T-cell-B-cell cooperative level

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    8/35

    T Cell Positive & Negative Selection in the Thymus

    MHC-restriction is not preprogrammed into T cells

    It is acquired

    (a)by contact with humoral factors and

    (b)by physical interaction of TCR-expressing cells

    with MHC molecule-expressing cells during T-celldevelopment in the thymus

    Positive and negative thymic selection is a life or

    death process for the developing T cell:

    Positive selection for self-MHC-restricted cells Negative selection of autoreactive T cells

    Mature T cells are self-MHC-restricted and self-

    tolerantbecause all thymocytes whose TCRs show

    strong recognition of self Ags are eliminated

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    9/35

    IL-2 synthesis is controlled by

    costimulatory signals CTLA-4 is a CD28

    homologue that issynthesized after the

    activation of T cell.

    When CTLA-4ligates B7 it blocksactivation signals

    that is No more IL-2is synthesizedleading to cell death

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    10/35

    Ags can induce any of the following:

    1. Clonal abortion:1. multivalent antigen can, when given in appropriate

    concentrations, cause immature B cells to abort by

    preventing their further differentiation

    Tolerizability ofpre-B cells is high Clonal deletion:

    very strong negative signals (missing Ag; absence of TH)

    can cause deletion of mature B cells

    Clonal anergy: intermediate concentration of multivalent antigen allows

    pre-B cells to develop into morphologically normal B

    cells, with normal numbers of immunoglobulin receptors,

    but renders them profoundly anergic

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    11/35

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    12/35

    T cell & B cell tolerance Because the thymus activity decreases into adulthood most T cell lines

    are present after birth

    The clone that dies or becomes tolerant will not or only slowly be

    replaced with active T cells T cell tolerance stays for long time

    B cells are made life long in the bone marrow

    Later encounter with immunogenic Ag would activate the new B cells

    B cell tolerance

    is shorter

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    13/35

    Advantages & disadvantages of tolerance

    Advantages1. Self-tolerance is essential for the function of the immune

    system

    2. Tolerance to foreign tissue grafts

    3. Gene therapy4. Control of damaging immune responses such as:

    i. Hypersensitivity

    ii. Autoimmune diseases

    Disadvantages1. Tolerance to certain foreign antigens that cause disease such

    as bacterial infections

    2. Tolerance to some self-antigens associated with cancer

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    14/35

    Autoimmunity/Objectives Define autoimmunity

    Know the multiple etiologies for autoimmune diseaseand the central role of helper T cells

    Describe

    cell-mediated autoimmunity leading to autoimmune

    disease antibody-mediated autoimmunity leading to

    autoimmune disease

    List other factors that may lead to autoimmune

    disease Discuss some of the approaches used in the

    treatment of autoimmune diseases; appreciate thepreventive approaches to specifically eliminate the

    causes

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    15/35

    Autoimmunity, definition, mechanism

    Autoimmunity:

    The immuneresponse of the

    body with

    antibodies or

    cell-mediatedimmunity

    to self-tissues or

    antigens,

    resulting inpathological

    consequences

    and

    autoimmune

    disease

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    16/35

    Etiologies of autoimmune diseases Genetic factors:

    Involvement of genetics is evidenced by the fact that monozygotictwins, dizygotic twins and family members have increased

    predisposition for certain diseases. Such inheritance is polygenic.

    Examples:

    SLE (anti-dsDNA Abs)

    Type 1 diabetes (>14 genes are involved)

    HLA genes are associated with several autoimmune diseases

    Environmental factors:

    They trigger autoimmune diseases. There are Ags that aresequestered from the lymphoid system. Examples:

    Lens and uveal proteins of the eye

    Spermatozoa.

    Accidents might end the sequestration of such Ags leading toautoimmunity

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    17/35

    Tolerance Autoimmunity1. Absence of TH cells:

    Low dose of Ag T-cell

    tolerance

    B cells are not affected

    but because TH is

    lacking No auto-Abproduction

    2. Control by Ts

    3. Absence of MHC II on

    potential target cells

    1. Bypass of TH absence

    leads to autoimmunity

    2. Impairment of Ts can

    lead to autoimmune

    response as result of

    primary

    immunodeficiency or

    anti-Ts Abs

    3. Gaining the ability ofpresenting their Ag to

    TH They become

    APC

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    18/35

    Mechanisms of bypassing the

    absence of TH cells1. Provision of an altered determinant capable

    of activating TH cells

    2.

    Polyclonal activation of B cells3. Bacterial & viral infections:

    Streptococcal infections elicit Ab that cross-reacts with normal tissue of the heart

    leading to autoimmune disease4. Bacteria and EBV can act as adjuvant leading

    to polyclonal activation and autoimmuneresponse

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    19/35

    Postulated mechanisms of autoimmunity

    In this proposed model of an

    organ-specific T cell-mediatedauto-immune disease, variousgenetic loci may confersusceptibility to autoimmunity,

    probably by influencing the

    maintenance of self-tolerance Environmental triggers, such as

    infections and

    other inflammatory stimuli

    promote the influx of lymphocytes

    into tissues and

    the activation of self-reactive T cells,

    resulting in tissue injury

    Fig 9-3

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    20/35

    Central T cell tolerance

    Negative selection, or deletion Strong recognition of self antigens by immature T cells in the

    thymus may lead to death of the cells

    Development of regulatory T cells that enter peripheral tissues

    May result from self-antigen recognition in the thymus

    Fig 9-4 (CD4 & DC8)

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    21/35

    T cell

    anergy

    An antigen presented by costimulator-expressing antigen-presenting cells (APCs) induces a normal T cell response.

    If the T cell recognizes antigen without costimulation, or

    in the presence ofCTLA-4-B7 interactions,

    the T cell fails to respond and is rendered incapable of respondingeven if the antigen is subsequently presented by costimulator-

    expressing APCs

    Fig 9-5

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    22/35

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    23/35

    Activation-induced

    death of T cells

    1. T cells respond to Ag presented bynormal APCs by

    secreting IL-2,

    expressing anti-apoptotic proteins,

    and undergoing proliferation and

    differentiation.

    2. Restimulation ofrecently activated Tcells by Ag leads to:

    coexpression ofFas and FasL,

    engagement of Fas, and apoptotic death of the T cells

    FasL on one T cell may engage Faseither

    on a neighboring cell or

    on the same cell

    3. Fas-independent activation-induced celldeath ofimmature T cell results fromexpression of intracellularpro-apoptoticproteinsbecause of

    Ag recognition by T cells withoutcostimulation or

    innate immunity

    Fig9-61

    2

    3

    Death R.

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    24/35

    T cell-mediated

    suppression of immune

    responses

    In a normal response, T cellsrecognize Ag and proliferate anddifferentiate into effector cells

    A typical TH1 response APCs secrete IL-12, which stimulates

    differentiation of the naive T cells intoTH1 effectors that produce IFN- andactivate macrophages in the effectorphase of the response

    Some T cells may differentiate intoregulatory cells in the peripheraltissues or the thymus

    Regulatory cells inhibit the

    activation and differentiation ofnaive T cells

    by contact-dependent mechanisms, or

    they may secrete cytokines thatinhibit the effector phase of T cellresponses

    Fig9-7

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    25/35

    Tolerance or activation? Features of protein antigens that influence the choice between T

    cell tolerance and activation

    Why the self antigens induce tolerance and microbial antigensstimulate T cell-mediated immune responses?

    Fig 9-8

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    26/35

    Negative selection and receptor editing in

    immature B lymphocytes

    An immature B cell that strongly recognizes self antigens

    E

    .g. a multivalent self Ag with several epitopes in the bonemarrow is

    killedby apoptosis or

    Receptor editing:

    changes its antigen receptor by making a new light chain with

    different specificity

    Fig9-9

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    27/35

    Peripheral

    tolerance in

    B cells

    A. A mature B cell that recognizes a self Ag without T cell help is

    functionally inactivated & becomes incapable of responding to

    that Ag

    B. B cells that are partially activated by recognition of self Ags

    without T cell help may be excluded from lymphoid follicles and

    may die by apoptosis because they are deprived of survival

    stimuli

    Fig9-10

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    28/35

    Autoimmune disease association with alleles of MHC locus

    Several lines of evidence support such association:

    Family and linkage studies show that individuals who inheritparticular HLA alleles are more likely to develop someautoimmune diseases than individuals lacking these alleles ("relativerisk").

    Selected examples of HLA disease associations are listed. For

    instance, individuals who have the HLA-B27 allele are 90

    to100

    times more likely to develop the disease ankylosing spondylitisthan B27-negative individuals; other diseases show varying degreesof association with other HLA alleles.

    Breeding studies in animals have shown that the incidence of someautoimmune diseases correlates strongly with the inheritance of

    particular MHC alleles (e.g., insulin-dependent [type 1] diabetesmellitus with the mouse class II allele called I-Ag7).

    Genome scanning studies have also revealed the association of MHCwith autoimmune diseases in humans and mice (e.g., HLA-DR andtype 1 diabetes in humans). See next, Fig9-11:

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    29/35

    Ankylosing spondylitis Progressive deformity due to ankylosing

    spondylitis over a period of 26 years

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    30/35

    Association of autoimmune diseases with alleles of the

    MHC locus

    MHC IIallele

    Fig9-11

    Skin disease characterized by

    groups of itching blisters

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    31/35

    The roles

    of somenon-MHC

    genes in

    auto-

    immunity

    Some genes other than MHC genes may contribute to the

    development of autoimmune diseases.

    Lpr = Mouse mutation "lymphoproliferation"

    gld = "generalized lymphoproliferative disease

    AICD, activation-induced cell death

    ALPS, autoimmune lymphoproliferative syndrome

    AutoImmuneRegulator

    polyEndocrine

    Fig9-12

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    32/35

    Mechanisms

    by which

    microbesmay promote

    auto-

    immunityA. Normally, encounter of mature T cells with self Ags presented by

    resting APCs results in peripheral tolerance by anergy ordeletion

    B. Microbes may activate the APCs to express costimulators; and

    when these APCs present self Ags, the specific T cells are activatedrather than rendered tolerant.

    C. Some microbial Ags may cross-react with self antigens (mimicry)

    Therefore, immune responses initiated by the microbes may becomedirected at self cells and tissues

    Molecular mimicry applies to T cells and self-reactive B cells

    Fig.9-13

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    33/35

    Autoimmune diseases1. Antibody-mediated autoimmunity

    1. Autoimmune hemolytic anemia2. Myasthenia gravis

    3. Graves' disease

    2. Immune complex-mediated autoimmunity

    1. Systemic lupus erythematosus (SLE)3. T-Cell-mediated autoimmunity:

    1. Multiple sclerosis

    2. Type I diabetes mellitus

    3. Hashimoto's thyroiditis4. Antibody- & T-cell-mediated autoimmune

    disease1. Rheumatoid arthritis

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    34/35

    Myasthenia

    gravis

  • 8/7/2019 Immuno12 &13 Tolerance & Autoimmunity

    35/35

    Rheumatoid Arthritis

    Chronic, inflammatory joint disease. Serum and synovial fluid of patients contain

    Rheumatoid factor

    IgM and IgG antibodies bound to Fc fragment of

    normal IgG

    Synovial membranes and blood vessels containrheumatoid factor and normal IgG, which attractPMN causing inflammation

    In active disease the patients have

    low titers of complement and

    high titers of rheumatoid factor